The Combination of Anti-CTLA-4 and PD1-/- Mice Unmasks the Potential of Isoniazid and Nevirapine to Cause Liver Injury

Chemical Research in Toxicology

Volumn 28, Issue 12, 2015, Pages 2287-2291

  Mak, Alastair ^a   Uetrecht, Jack ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; GLUTAMATE DEHYDROGENASE; ISONIAZID; NEVIRAPINE; GRANZYME; GZMB PROTEIN, MOUSE; MONOCLONAL ANTIBODY; PDCD1 PROTEIN, MOUSE; PROGRAMMED DEATH 1 RECEPTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; COVALENT BOND; FEMALE; LYMPHOCYTIC INFILTRATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; TH17 CELL; TOXIC HEPATITIS; ANIMAL; DISEASE MODEL; DRUG EFFECTS; FLOW CYTOMETRY; GENE INACTIVATION; GENETICS; HUMAN; LIVER;

ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; FEMALE; FLOW CYTOMETRY; GENE KNOCKOUT TECHNIQUES; GRANZYMES; HUMANS; ISONIAZID; LIVER; MICE; NEVIRAPINE; PROGRAMMED CELL DEATH 1 RECEPTOR;

EID: 84951326107     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/acs.chemrestox.5b00305     Document Type: Article

References (23)

1. Uetrecht, J. (2001) Prediction of a new drug's potential to cause idiosyncratic reactions Curr. Opin. Drug Discovery Dev. 4, 55-59
2. Metushi, I. G., Hayes, M. A., and Uetrecht, J. (2015) Treatment of PD-1(-/-) mice with amodiaquine and anti-CTLA-4 leads to liver injury similar to idiosyncratic liver injury in patients Hepatology 61, 1332-1342 10.1002/hep.27549
3. Parry, R. V., Chemnitz, J. M., Frauwirth, K. A., Lanfranco, A. R., Braunstein, I., Kobayashi, S. V., Linsley, P. S., Thompson, C. B., and Riley, J. L. (2005) CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms Mol. Cell. Biol. 25, 9543-9553 10.1128/MCB.25.21.9543-9553.2005
4. Foureau, D. M., Walling, T. L., Maddukuri, V., Anderson, W., Culbreath, K., Kleiner, D. E., Ahrens, W. A., Jacobs, C., Watkins, P. G., and Fontana, R. J. et al. 2015, Comparative analysis of portal hepatic infiltrating leukocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis Clin. Exp. Immunol. 180, 40-51 10.1111/cei.12558
5. Maddrey, W. C. and Boitnott, J. K. (1973) Isoniazid hepatitis Ann. Intern. Med. 79, 1-12 10.7326/0003-4819-79-1-1
6. Warrington, R. J., McPhilips-Feener, S., and Rutherford, W. (1982) The predictive value of the lymphocyte transformation test in isoniazid-associated hepatitis Clin. Exp. Allergy 12, 217-222 10.1111/j.1365-2222.1982.tb02521.x
7. Warrington, R. J., Tse, K. S., Gorski, B. A., Schwenk, R., and Sehon, A. H. (1978) Evaluation of isoniazid-associated hepatitis by immunological tests Clin. Exp. Immunol. 32, 97-104
8. Metushi, I. G., Sanders, C., Lee, W. M., and Uetrecht, J. (2014) Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure Hepatology 59, 1084-1093 10.1002/hep.26564
9. Mitchell, J. R., Zimmerman, H. J., Ishak, K. G., Thorgeirsson, U. P., Timbrell, J. A., Snodgrass, W. R., and Nelson, S. D. (1976) Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis Ann. Intern. Med. 84, 181-192 10.7326/0003-4819-84-2-181
10. Black, M., Mitchell, J. R., Zimmerman, H. J., Ishak, K. G., and Epler, G. R. (1975) Isoniazid-associated hepatitis in 114 patients Gastroenterol. 69, 289-302
11. Metushi, I. G. and Uetrecht, J. (2014) Isoniazid-induced liver injury and immune response in mice J. Immunotoxicol. 11, 383-392 10.3109/1547691X.2013.860644
12. Metushi, I. G., Cai, P., Vega, L., Grant, D. M., and Uetrecht, J. (2014) Paradoxical attenuation of autoimmune hepatitis by oral isoniazid in wild-type and N-acetyltransferase-deficient mice Drug Metab. Dispos. 42, 963-973 10.1124/dmd.113.056622
13. Pollard, R. B., Robinson, P., and Dransfield, K. (1998) Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection Clin. Ther. 20, 1071-1092 10.1016/S0149-2918(98)80105-7
14. Hall, D. B. and MacGregor, T. R. (2007) Case-control exploration of relationships between early rash or liver toxicity and plasma concentrations of nevirapine and primary metabolites HIV Clin. Trials 8, 391-399 10.1310/hct0806-391
15. Stern, J. O., Robinson, P. A., Love, J., Lanes, S., Imperiale, M. S., and Mayers, D. L. (2003) A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients JAIDS, J. Acquired Immune Defic. Syndr. 34, S21-33 10.1097/00126334-200309011-00005
16. Sharma, A. M., Li, Y., Novalen, M., Hayes, M. A., and Uetrecht, J. (2012) Bioactivation of nevirapine to a reactive quinone methide: implications for liver injury Chem. Res. Toxicol. 25, 1708-1719 10.1021/tx300172s
17. Metushi, I. G., Nakagawa, T., and Uetrecht, J. (2012) Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats Chem. Res. Toxicol. 25, 2567-2576 10.1021/tx300341r
18. Mak, A. and Uetrecht, J. (2015) Immunization with amodiaquine-modified hepatic proteins prevents amodiaquine-induced liver injury J. Immunotoxicol. 12, 361-367 10.3109/1547691X.2014.983660
19. Mak, A. and Uetrecht, J. (2015) The Role of CD8 T cells in Amodiaquine-Induced Liver Injury in PD1-/- Mice Cotreated with Anti-CTLA-4 Chem. Res. Toxicol. 28, 1567-1573 10.1021/acs.chemrestox.5b00137
20. Metushi, I. G., Cai, P., Dervovic, D., Liu, F., Lobach, A., Nakagawa, T., and Uetrecht, J. (2015) Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset J. Immunotoxicol. 12, 247-260 10.3109/1547691X.2014.934977
21. Cripps, J. G., Wang, J., Maria, A., Blumenthal, I., and Gorham, J. D. (2010) Type 1 T helper cells induce the accumulation of myeloid-derived suppressor cells in the inflamed Tgfb1 knockout mouse liver Hepatology 52, 1350-1359 10.1002/hep.23841
22. Lan, R. Y., Salunga, T. L., Tsuneyama, K., Lian, Z. X., Yang, G. X., Hsu, W., Moritoki, Y., Ansari, A. A., Kemper, C., Price, J., Atkinson, J. P., Coppel, R. L., and Gershwin, M. E. (2009) Hepatic IL-17 responses in human and murine primary biliary cirrhosis J. Autoimmun. 32, 43-51 10.1016/j.jaut.2008.11.001
23. Chakraborty, M., Fullerton, A. M., Semple, K., Chea, L. S., Proctor, W. R., Bourdi, M., Kleiner, D. E., Zeng, X., Ryan, P. M., Dagur, P. K., Berkson, J. D., Reilly, T. P., and Pohl, L. R. (2015) Drug-induced allergic hepatitis developed in mice when myeloid-derived suppressor cells were depleted prior to halothane treatment Hepatology 62, 546-557 10.1002/hep.27764